BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 26842965)

  • 1. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function.
    Sharma A; Lyashchenko AK; Lu L; Nasrabady SE; Elmaleh M; Mendelsohn M; Nemes A; Tapia JC; Mentis GZ; Shneider NA
    Nat Commun; 2016 Feb; 7():10465. PubMed ID: 26842965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
    Scekic-Zahirovic J; Oussini HE; Mersmann S; Drenner K; Wagner M; Sun Y; Allmeroth K; Dieterlé S; Sinniger J; Dirrig-Grosch S; René F; Dormann D; Haass C; Ludolph AC; Lagier-Tourenne C; Storkebaum E; Dupuis L
    Acta Neuropathol; 2017 Jun; 133(6):887-906. PubMed ID: 28243725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defects in synapse structure and function precede motor neuron degeneration in Drosophila models of FUS-related ALS.
    Shahidullah M; Le Marchand SJ; Fei H; Zhang J; Pandey UB; Dalva MB; Pasinelli P; Levitan IB
    J Neurosci; 2013 Dec; 33(50):19590-8. PubMed ID: 24336723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice.
    Devoy A; Kalmar B; Stewart M; Park H; Burke B; Noy SJ; Redhead Y; Humphrey J; Lo K; Jaeger J; Mejia Maza A; Sivakumar P; Bertolin C; Soraru G; Plagnol V; Greensmith L; Acevedo Arozena A; Isaacs AM; Davies B; Fratta P; Fisher EMC
    Brain; 2017 Nov; 140(11):2797-2805. PubMed ID: 29053787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS.
    Xia R; Liu Y; Yang L; Gal J; Zhu H; Jia J
    Mol Neurodegener; 2012 Mar; 7():10. PubMed ID: 22443542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha.
    Kia A; McAvoy K; Krishnamurthy K; Trotti D; Pasinelli P
    Glia; 2018 May; 66(5):1016-1033. PubMed ID: 29380416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Regulatory Circuitry Between Gria2, miR-409, and miR-495 Is Affected by ALS FUS Mutation in ESC-Derived Motor Neurons.
    Capauto D; Colantoni A; Lu L; Santini T; Peruzzi G; Biscarini S; Morlando M; Shneider NA; Caffarelli E; Laneve P; Bozzoni I
    Mol Neurobiol; 2018 Oct; 55(10):7635-7651. PubMed ID: 29430619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular regression precedes motor neuron loss in the FUS (1-359) ALS mouse model.
    Crivello M; Hogg MC; Jirström E; Halang L; Woods I; Rayner M; Coughlan KS; Lewandowski SA; Prehn JHM
    Dis Model Mech; 2019 Aug; 12(8):. PubMed ID: 31383794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.
    Picchiarelli G; Demestre M; Zuko A; Been M; Higelin J; Dieterlé S; Goy MA; Mallik M; Sellier C; Scekic-Zahirovic J; Zhang L; Rosenbohm A; Sijlmans C; Aly A; Mersmann S; Sanjuan-Ruiz I; Hübers A; Messaddeq N; Wagner M; van Bakel N; Boutillier AL; Ludolph A; Lagier-Tourenne C; Boeckers TM; Dupuis L; Storkebaum E
    Nat Neurosci; 2019 Nov; 22(11):1793-1805. PubMed ID: 31591561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways.
    Blokhuis AM; Koppers M; Groen EJN; van den Heuvel DMA; Dini Modigliani S; Anink JJ; Fumoto K; van Diggelen F; Snelting A; Sodaar P; Verheijen BM; Demmers JAA; Veldink JH; Aronica E; Bozzoni I; den Hertog J; van den Berg LH; Pasterkamp RJ
    Acta Neuropathol; 2016 Aug; 132(2):175-196. PubMed ID: 27164932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALS-linked FUS exerts a gain of toxic function involving aberrant p38 MAPK activation.
    Sama RR; Fallini C; Gatto R; McKeon JE; Song Y; Rotunno MS; Penaranda S; Abdurakhmanov I; Landers JE; Morfini G; Brady ST; Bosco DA
    Sci Rep; 2017 Mar; 7(1):115. PubMed ID: 28273913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.
    Scekic-Zahirovic J; Sendscheid O; El Oussini H; Jambeau M; Sun Y; Mersmann S; Wagner M; Dieterlé S; Sinniger J; Dirrig-Grosch S; Drenner K; Birling MC; Qiu J; Zhou Y; Li H; Fu XD; Rouaux C; Shelkovnikova T; Witting A; Ludolph AC; Kiefer F; Storkebaum E; Lagier-Tourenne C; Dupuis L
    EMBO J; 2016 May; 35(10):1077-97. PubMed ID: 26951610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN.
    Groen EJ; Fumoto K; Blokhuis AM; Engelen-Lee J; Zhou Y; van den Heuvel DM; Koppers M; van Diggelen F; van Heest J; Demmers JA; Kirby J; Shaw PJ; Aronica E; Spliet WG; Veldink JH; van den Berg LH; Pasterkamp RJ
    Hum Mol Genet; 2013 Sep; 22(18):3690-704. PubMed ID: 23681068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice.
    So E; Mitchell JC; Memmi C; Chennell G; Vizcay-Barrena G; Allison L; Shaw CE; Vance C
    Hum Mol Genet; 2018 Feb; 27(3):463-474. PubMed ID: 29194538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis.
    Korobeynikov VA; Lyashchenko AK; Blanco-Redondo B; Jafar-Nejad P; Shneider NA
    Nat Med; 2022 Jan; 28(1):104-116. PubMed ID: 35075293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo stress granule misprocessing evidenced in a FUS knock-in ALS mouse model.
    Zhang X; Wang F; Hu Y; Chen R; Meng D; Guo L; Lv H; Guan J; Jia Y
    Brain; 2020 May; 143(5):1350-1367. PubMed ID: 32358598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss and gain of FUS function impair neuromuscular synaptic transmission in a genetic model of ALS.
    Armstrong GA; Drapeau P
    Hum Mol Genet; 2013 Nov; 22(21):4282-92. PubMed ID: 23771027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.
    Yang C; Danielson EW; Qiao T; Metterville J; Brown RH; Landers JE; Xu Z
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6209-E6218. PubMed ID: 27681617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant axon branching via Fos-B dysregulation in FUS-ALS motor neurons.
    Akiyama T; Suzuki N; Ishikawa M; Fujimori K; Sone T; Kawada J; Funayama R; Fujishima F; Mitsuzawa S; Ikeda K; Ono H; Shijo T; Osana S; Shirota M; Nakagawa T; Kitajima Y; Nishiyama A; Izumi R; Morimoto S; Okada Y; Kamei T; Nishida M; Nogami M; Kaneda S; Ikeuchi Y; Mitsuhashi H; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    EBioMedicine; 2019 Jul; 45():362-378. PubMed ID: 31262712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.